IL6, interleukin 6, 3569

N. diseases: 2367; N. variants: 22
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.300 Biomarker phenotype BEFREE Plasma cytokine concentrations increased profoundly during endotoxaemia (control group: tumor necrosis factor alpha [TNF-α] from 14 [9-16] pg ml<sup>-1</sup> at baseline to 480 [284-709] pg ml<sup>-1</sup> at 1.5 h after LPS; interleukin-6 [IL-6] from 4 [4-4] pg ml<sup>-1</sup> at baseline to 659 [505-1018] pg ml<sup>-1</sup> at 2 h after LPS). 31084985 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.300 Biomarker phenotype BEFREE The α7 nAChR partial agonist GTS-21 reduces secretion of pro-inflammatory cytokines including interleukin-6 (IL6) and tumor-necrosis factor (TNF) in models of endotoxemia and sepsis, and its anti-inflammatory effects are widely ascribed to α7 nAChR activation. 30947238 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.300 AlteredExpression phenotype BEFREE LAH also significantly reduced the concentration of tumour cell necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both serum and colon and decreased the level of lipopolysaccharides (LPS) in serum and feces, leading to reduced systematic inflammation and metabolic endotoxemia. 31099356 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.300 Biomarker phenotype BEFREE 20TT in the heat increased I-FABP and elevated inflammatory cytokines (IL-6 and TNF-α) compared to pre-exercise values but did not result in endotoxemia. 31565753 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.300 AlteredExpression phenotype BEFREE In vivo, levels of IL-1β, IL-6, and TNFα in the lungs and liver were markedly reduced during endotoxemia in IL-37Tg mice but not observed in IL-37D20ATg mice. 30792349 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.300 Biomarker phenotype BEFREE Fatigue in HD patients may be related to endotoxemia and inflammation through IL-6. 31541903 2020